Cyclin D1–CDK4/6 phosphorylates GTSE1 in cancer cells, preventing its degradation and sustaining high levels across the cell cycle, which enhances proliferation and correlates with poor prognosis.

MINNEAPOLIS (AP) — Martín Pérez, zurdo de los Medias Blancas de Chicago, sufrió un tirón en el flexor del brazo izquierdo, y el manager Will Venable dijo que el equipo espera que vuelva a lanzar este ...

Listening to our favorite music activates the same parts of the brain as food and sex, reveals new research. The study showed ...

A new pill, tavapadon, has shown potential in easing Parkinson’s symptoms while limiting side effects. In patients taking at ...

The U.S. Food and Drug Administration has approved a self-injection version of Vyvgart Hytrulo (efgartigimod alfa and ...

Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy, ...

The India launch of Eli Lilly's Mounjaro in India has triggered a huge wave of enquiries from those looking for its ...

General Manager John Spytek joins Bucky Brooks and Rhett Lewis to discuss his mindset for the 2025 NFL Draft, top 30 visits, ...

The highly selective partial agonist at D1 and D5 receptors significantly improves motor function in patients recently ...

Not everyone with ADHD responds to stimulants like Ritalin, which increase dopamine levels in the brain. Now, new research ...

Designer receptors exclusively activated by designer drugs (DREADDs ... We then selectively expressed hM3Ds in D1 medium spiny neurons (D1-MSNs) and found that hM3Ds was able to activate the ...